A detailed history of River Street Advisors LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, River Street Advisors LLC holds 3,517 shares of LLY stock, worth $3.22 Million. This represents 1.85% of its overall portfolio holdings.

Number of Shares
3,517
Previous 3,512 0.14%
Holding current value
$3.22 Million
Previous $2.05 Billion 33.65%
% of portfolio
1.85%
Previous 1.63%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 17, 2024

BUY
$592.2 - $792.28 $2,961 - $3,961
5 Added 0.14%
3,517 $2.74 Billion
Q4 2023

Jan 29, 2024

BUY
$525.19 - $619.13 $27,835 - $32,813
53 Added 1.53%
3,512 $2.05 Billion
Q3 2023

Oct 26, 2023

SELL
$434.7 - $599.3 $10,432 - $14,383
-24 Reduced 0.69%
3,459 $1.86 Billion
Q2 2023

Jul 21, 2023

SELL
$350.74 - $468.98 $41,036 - $54,870
-117 Reduced 3.25%
3,483 $1.63 Billion
Q1 2023

May 03, 2023

BUY
$310.63 - $364.82 $1.12 Million - $1.31 Million
3,600 New
3,600 $1.24 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $869B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track River Street Advisors LLC Portfolio

Follow River Street Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of River Street Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on River Street Advisors LLC with notifications on news.